Skip to content

Study on the effect of ultrasound guided percutaneous injection of corticosteroid and PRP on patients with lumbar disc herniation

Study on the effect of ultrasound guided percutaneous injection of corticosteroid and PRP on patients with lumbar disc herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011825
Enrollment
Unknown
Registered
2017-07-02
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protrusion of lumbar intervertebral disc

Interventions

the corticosteroid group:ultrasound guided Injection of corticosteroid through intervertebral foramen
the PRP group:ultrasound guided Injection of PRP through intervertebral foramen

Sponsors

Sun Yat-sen Memorial Hospital,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) aged 20-60 years; (2) low back pain with unilateral lower limb radioactive pain, duration of more than 3months; (3) lumbar disc herniation were diagnosed by MRI or CT, and consistent with the clinical symptoms and signs; (4) no symptoms of nerve damage symptoms; (5) the patients have got conservative treatment, including physical therapy, the manipulation and non morphine treatment; (6) the degree of pain (VAS) is more than 5 and there are obvious nerve root irritation symptoms and clinical signs; (7) who had no history of spinal surgery.

Exclusion criteria

Exclusion criteria: (1) infection; (2) spinal tumors or tuberculosis; (3) severe diabetes; (4) a history of drug abuse or oral anticoagulation; (5) multi segmental lumbar disc herniation, spinal deformity or existing structure, spinal stenosis; (6) abnormal psychological, cognitive disorders; (7) not suitable for local injection; (8) had received prior treatment for injection in the past 3months, such as the injection of nerve root, sacral injection tube; (9) during pregnancy; (10) allergic to the drug used in the study; (11) clinical diagnosis of heart disease, liver and kidney dysfunction, blood system diseases.

Design outcomes

Primary

MeasureTime frame
Pressure pain thresholds;visual analogue scale;Oswestry disability index;SF-36;

Secondary

MeasureTime frame
F wave latency;the rate of F wave;

Countries

China

Contacts

Public ContactChao Ma

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

ma_chao99@126.com+86 18127880016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026